IP Library Granted Patent US 7,384,418
Granted Patent B2
US 7,384,418 · App. 10/721,701 · Granted Jun 10, 2008

Methods and devices for delivery of agents to breast milk ducts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,384,418
App. No.
10/721,701
Granted
Jun 10, 2008
Kind
B2
Abstract

The invention provides devices, kits and methods for delivering an agent to a breast milk duct. Intraductal agent delivery provides an opportunity to treat a breast condition locally and avoid the pitfalls of systemic drug delivery for a local condition. Time-released agents delivered into the ducts using an intraductal device or formulation reduces the frequency of intraductal administration required for desired efficacy over time. The methods include methods of treating a breast condition, including the conditions of cancer or precancer.

Claims (34)

1. A device for delivering an agent to a breast milk duct over time, said device comprising: a unit for holding the agent to be delivered to the breast duct, said unit being sized and configured to be positioned and supported on a nipple, and an elongated member for delivering the agent from the unit to the breast duct, said elongated member being in communication with said unit, being sized for positioning within the breast duct, and having a distal terminal end for positioning within the breast duct, said distal end having an atraumatic tip.

2. The device to claim 1 wherein said unit comprises a reservoir for holding the agent to be delivered to the elongated member.

3. The device to claim 2 wherein said reservoir is sized to hold a volume of the agent in the range of from about 0.001 ml to 10 ml.

4. The device to claim 2 wherein said unit comprises a pump for delivering the agent from the reservoir to the elongated member when the elongated member is positioned within the breast duct.

5. The device of claim 4 wherein said pump is osmotic.

6. The device of claim 1 wherein said unit is capable of delivering a volume of the agent in a range from about 0.0001 ml per day to about 0.001 ml per hour.

7. The device of claim 1 wherein said unit comprises an osmotic pump for delivering the agent to the elongated member when the elongated member is positioned within the breast duct.

8. The device of claim 1 wherein said unit comprises a microchip for delivering the agent to the elongated member when the elongated member is positioned within the breast duct.

9. The device of claim 1 wherein said elongated member extends substantially perpendicular to a nipple engaging surface of the unit.

10. The device of claim 1 wherein said elongated member includes a portion for securely maintaining the elongated member within the breast duct.

11. The device of claim 10 wherein said portion of the elongated member includes a protruding member for engaging a wall of the breast duct.

12. A device for delivering an agent to a breast milk duct over time, said device comprising: a unit for holding the agent to be delivered to the breast duct, said unit being sized and configured for residing on a nipple surface, and an elongated member for delivering the agent from the unit to the breast duct, said elongated member being in communication with said unit, sized for positioning within the breast duct, having a distal terminal end for positioning within the breast duct, said distal end having an atraumatic end, and having a retaining member for holding the elongated member in the breast duct.

13. The device of claim 12 wherein said device includes an outer boundary that is shaped and configured for being fully supported on a nipple.

14. The device to claim 12 wherein said unit comprises a reservoir for holding the agent to be delivered to the elongated member.

15. The device according to claim 14 wherein said reservoir is sized to hold a volume of the agent in the range of from about 0.001 ml to 10 ml.

16. The device to claim 15 wherein said unit comprises a pump for delivering the agent from the reservoir to the elongated member when the elongated member is positioned within the breast duct.

17. The device of claim 16 wherein said pump is osmotic.

18. The device of claim 12 wherein said unit is capable of delivering a volume of the agent in a range from about 0.0001 ml per day to about 0.001 ml per hour.

19. The device of claim 12 wherein said unit comprises an osmotic pump for delivering the agent to the elongated member when the elongated member is positioned within the breast duct.

20. The device of claim 12 wherein said unit comprises a microchip for delivering the agent to the elongated member when the elongated member is positioned within the breast duct.

21. The device of claim 12 wherein said elongated member extends substantially perpendicular to a nipple engaging surface of the unit.

22. The device of claim 12 wherein said remaining member includes a protrusion for engaging a wall of the breast duct.

23. A device for delivering an agent to a breast milk duct over time, said device comprising: an indwelling unit for holding the agent to be delivered to the breast duct, said indwelling unit being sized and configured for being positioned and maintained within a portion of a breast duct, said indwelling unit having an atraumatic distal end for positioning within the duct, and an elongated member extending from said unit, wherein said elongated member can be positioned to extend out of said breast duct when said indwelling unit is positioned within the breast duct.

24. The device of claim 23 wherein said elongated member includes a tether that provides retrieval of the indwelling unit from within the breast duct.

25. The device of claim 23 wherein said unit includes a reservoir and said elongated member includes a lumen for delivering fluid to said reservoir when said reservoir is positioned within the breast duct.

26. The device of claim 23 wherein said elongated member includes an internal lumen for delivering a fluid to the indwelling unit.

27. The device according to claim 23 wherein said indwelling unit comprises a reservoir for holding the agent to be delivered to the breast duct.

28. The device of claim 27 wherein said reservoir is sized to hold a volume of the agent in the range of from about 0.001 ml to 10 ml.

29. The device of claim 28 wherein said indwelling unit comprises a pump for delivering the agent from the reservoir to the breast duct.

30. The device of claim 29 wherein said pump is osmotic.

31. The device of claim 23 wherein said indwelling unit is capable of delivering a volume of the agent in a range from about 0.0001 ml per day to about 0.001 ml per hour.

32. The device of claim 23 wherein said indwelling unit comprises an osmotic pump for delivering the agent to the breast duct when the indwelling unit is located within the breast duct.

33. The device of claim 23 wherein said indwelling unit comprises a microchip for delivering the agent to the breast duct when the indwelling unit is positioned within the breast duct.

34. A device for delivering an agent to a breast milk duct over time, said device comprising: an indwelling unit for holding the agent to be delivered to the breast duct, said indwelling unit including a microchip and being sized and configured for being positioned and maintained within a portion of a breast duct, said indwelling unit having an atraumatic distal end for positioning within the duct, and an elongated member secured to the indwelling unit, wherein said elongated member extends out of the breast when the indwelling unit is positioned within the breast duct.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE CHANGE OF NAME PREVIOUSLY RECORDED AT REEL: 051783 FRAME: 0477. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 054372/0976 →
CHANGE OF NAME Recorded Feb 3, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 051783/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2012
From: CYTYC CORPORATION
To: HOLOGIC, INC.
Reel/Frame 027555/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2012
From: HOLOGIC, INC.
To: ATOSSA GENETICS, INC.
Reel/Frame 027555/0377 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →